ETF Managers Group, LLC
- SEC CIK
- 0001645173
- Latest filing
- Apr 18, 2023
LCTX holding history
Lineage Cell Therapeutics, Inc. in every 13F filed by ETF Managers Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LCTX overviewAll 13F holders of LCTXFull Q1 2023 holdings
- Shares (Q1 2023)
- 318,596
- Value
- $477.9K
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 318,596 | $477.9K | <0.1% | −35,395−10.0% | Reduced | Holders |
| Q4 2022 | 353,991 | $414.2K | <0.1% | +24,165+7.3% | Added | Holders |
| Q3 2022 | 329,826 | $373.0K | <0.1% | +24,892+8.2% | Added | Holders |
| Q2 2022 | 304,934 | $491.0K | <0.1% | +112,307+58.3% | Added | Holders |
| Q1 2022 | 192,627 | $289.0K | <0.1% | −15,108−7.3% | Reduced | Holders |
| Q4 2021 | 207,735 | $519.0K | <0.1% | +207,735 | New | Holders |